2022
DOI: 10.3390/ijms23158607
|View full text |Cite
|
Sign up to set email alerts
|

MATE1 Deficiency Exacerbates Dofetilide-Induced Proarrhythmia

Abstract: Dofetilide is a rapid delayed rectifier potassium current inhibitor widely used to prevent the recurrence of atrial fibrillation and flutter. The clinical use of this drug is associated with increases in QTc interval, which predispose patients to ventricular cardiac arrhythmias. The mechanisms involved in the disposition of dofetilide, including its movement in and out of cardiomyocytes, remain unknown. Using a xenobiotic transporter screen, we identified MATE1 (SLC47A1) as a transporter of dofetilide and foun… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 73 publications
0
3
0
Order By: Relevance
“…15,16 For example, the drugs metformin, dofetilide, pramipexole, and lamivudine, and also the endogenous sub stance creatinine are substrates for OCT2/ MATE. [17][18][19][20] Co-administration of MATE inhibitors, such as cimetidine, trimethoprim, and pyrimethamine, with renally secreted OCT2/MATE substrates lead to a reduced renal clearance (CL R ) and to some extent increased systemic exposure of the victim drugs. 21 Shim et al 22 as well as Ito et al 23 proposed N 1 methylnicotinamide (NMN) as possible biomarker for renal secretion of organic cations.…”
Section: Articlementioning
confidence: 99%
See 1 more Smart Citation
“…15,16 For example, the drugs metformin, dofetilide, pramipexole, and lamivudine, and also the endogenous sub stance creatinine are substrates for OCT2/ MATE. [17][18][19][20] Co-administration of MATE inhibitors, such as cimetidine, trimethoprim, and pyrimethamine, with renally secreted OCT2/MATE substrates lead to a reduced renal clearance (CL R ) and to some extent increased systemic exposure of the victim drugs. 21 Shim et al 22 as well as Ito et al 23 proposed N 1 methylnicotinamide (NMN) as possible biomarker for renal secretion of organic cations.…”
Section: Articlementioning
confidence: 99%
“…Organic cation transporter 2 works in coordinated fashion with the MATE proteins (MATE1 ( SLC47A1 ) and MATE2‐K ( SLC47A2 )), which are localized in the apical membrane of renal proximal tubular cells due to their overlapping substrate spectrum 15,16 . For example, the drugs metformin, dofetilide, pramipexole, and lamivudine, and also the endogenous substance creatinine are substrates for OCT2/MATE 17–20 . Co‐administration of MATE inhibitors, such as cimetidine, trimethoprim, and pyrimethamine, with renally secreted OCT2/MATE substrates lead to a reduced renal clearance (CL R ) and to some extent increased systemic exposure of the victim drugs 21 …”
mentioning
confidence: 99%
“…They found species-dependent differences for 2 and substrate-dependent differences for 3 out of 22 investigated compounds, showing that species-dependent differences should be considered when extrapolating data from mice to humans. In the paper “MATE1 Deficiency Exacerbates Dofetilide-Induced Proarrhythmia”, Uddin et al [ 13 ] found that Dofetilide, a class III antiarrhythmic drug, is a substrate of the multidrug and toxin extrusion protein 1 (MATE1). Dofetilide transport in cardiomyocytes and renal tubular cells is mediated by MATE1 and is highly sensitive to pharmacological inhibition, suggesting that these findings are important for optimizing polypharmacy regimens.…”
Section: Original Research Workmentioning
confidence: 99%